Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock
Not yet recruiting · NCT07569536 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Vasoplegia, cardiovascular disorder, toxic shock syndrome, vascular disorder | Not yet recruiting | Phase 3 | 2026-05-06 | NCT07569536 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire Dijon | 130 |
| Hospices Civils de Lyon | 429 |
18 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.